O2M Technologies is a device company developing oxygen imaging instruments for in vitro and in vivo measurements in tissue samples and in small animals. We use patented technology to generate 3D oxygen maps. Tissue oxygen maps obtained using our technology can be used to develop enhanced therapies. The examples include but not limited to: develop better artificial cell replacement devices, assist drug development, and probe vitality of artificial tissue grafts pre- and post-implantation, guide cancer radiation treatment, assess immunotherapy and chemotherapy outcomes.
MRIGNAYANI KOTECHA, PhD
CHIEF EXECUTIVE OFFICER
Dr. Mrignayani Kotecha is an expert in Applications of EPR Oximetry in regenerative medicine, NMR spectroscopy, MRI, biomaterials, and tissue engineering.
BORIS EPEL, PhD
CHIEF TECHNOLOGY OFFICER
Dr. Boris Epel is an expert in EPR oximetry with over 20 years of experience in EPR. His expertise is in instrumentation, software design and scientific basis of EPR oximetry.
HOWARD J. HALPERN, MD, PhD
Dr. Howard Halpern is an expert and pioneer in the field of EPR oximetry and its use for radiation treatment in solid tumors. He is also a practicing oncologist.
PRADEEP CHINTAGUNTA, PhD
Dr. Pradeep Chintagunta is Joseph T and Bernice S Lewis distinguished service professor of marketing at the University of Chicago Booth School. He has specific experience in the marketing practices of small businesses in emerging economies.
HAROLD M. SWARTZ, MD, MSPH, PhD
Dr. Harold Swartz MD, PhD, MSPH, is a professor of radiology at Dartmouth College Geisel School of Medicine. His current interests are focused on the measurement of oxygen in vivo to improve diagnosis and therapy in the wide range of pathophysiology.
O2M is supported by: